These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8858390)

  • 21. Pharmacotherapy in erectile dysfunction agents for self-injection programs and alternative application models.
    Hedlund H; Hedlund P
    Scand J Urol Nephrol Suppl; 1996; 179():129-38. PubMed ID: 8908679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient-reported pain with initial intracavernosal injection.
    Albaugh J; Ferrans CE
    J Sex Med; 2009 Feb; 6(2):513-9. PubMed ID: 19215617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracavernosal etilefrine self-injection therapy for recurrent priapism: one decade of follow-up.
    Teloken C; Ribeiro EP; Chammas M; Teloken PE; Souto CA
    Urology; 2005 May; 65(5):1002. PubMed ID: 15882751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A "Needling" Complication.
    Banerji JS; Govier FE
    Urology; 2016 Nov; 97():e5. PubMed ID: 27392650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of penile erection by intracavernosal and transurethral administration of novel nitric oxide donors in the cat.
    Champion HC; Bivalacqua TJ; Wang R; Kadowitz PJ; Keefer LK; Saavedra JE; Hrabie JA; Doherty PC; Hellstrom WJ
    J Urol; 1999 Jun; 161(6):2013-9. PubMed ID: 10332492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tadalafil and modifications in peak systolic velocity (Doppler spectrum dynamic analysis) in the cavernosal arteries of patients with type 2 diabetes after continuous tadalafil treatment.
    La Vignera S; Calogero AE; Cannizzaro MA; Condorelli R; Noto Z; Vicari E
    Minerva Endocrinol; 2006 Dec; 31(4):251-61. PubMed ID: 17213792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracavernosal sildenafil facilitates penile erection independent of the nitric oxide pathway.
    McAuley IW; Kim NN; Min K; Goldstein I; Traish AM
    J Androl; 2001; 22(4):623-8. PubMed ID: 11451359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy.
    Briganti A; Fabbri F; Salonia A; Gallina A; Chun FK; Dehò F; Zanni G; Suardi N; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2007 Sep; 52(3):702-7. PubMed ID: 17418936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective evaluation of efficacy and compliance with a multistep treatment approach for erectile dysfunction in patients after non-nerve sparing radical prostatectomy.
    Gontero P; Fontana F; Zitella A; Montorsi F; Frea B
    BJU Int; 2005 Feb; 95(3):359-65. PubMed ID: 15679794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axial penile rigidity: determinants and relation to hemodynamic parameters.
    Goldstein I; Udelson D
    Int J Impot Res; 1998 May; 10 Suppl 2():S28-33; discussion S49-51. PubMed ID: 9647958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retained needles during intracavernosal self-injection for erectile dysfunction treatment: a case report and systematic literature review.
    Meilika KN; Eid JF
    Sex Med; 2023 Apr; 11(2):qfad008. PubMed ID: 36970585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prolonged use of moxisylyte chlorhydrate (Icavex) by intracavernous self-injections in the treatment of impotence. Evaluation of long-term tolerance].
    Arvis G; Rivet G; Schwent B
    J Urol (Paris); 1996; 102(4):151-6. PubMed ID: 9091564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracavernosal injection of vascular endothelial growth factor improves erectile function in aged rats.
    Park K; Ahn KY; Kim MK; Lee SE; Kang TW; Ryu SB
    Eur Urol; 2004 Sep; 46(3):403-7. PubMed ID: 15306114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normal hemodynamic parameters do not always predict the presence of a rigid erection: a quantitative assessment of functional erectile impairment.
    Hatzichristou DG; Hatzimouratidis K; Tzortzis V; Apostolidis A; Bekos A; Ioannidis E
    Int J Impot Res; 2003 Apr; 15(2):99-104. PubMed ID: 12789388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology].
    de Boer BJ; Lycklama a Nijeholt AA; Kleinjans HA
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):783-7. PubMed ID: 11346917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis.
    Elhanbly S; Schoor R; Elmogy M; Ross L; Hegazy A; Niederberger C
    J Urol; 2002 Jan; 167(1):192-6. PubMed ID: 11743303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on oral treatments for male erectile dysfunction.
    Kalsi JS; Kell PD
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):267-74. PubMed ID: 15096134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feline penile erection induced by topical glans penis application of combination alprostadil and SEPA (Topiglan).
    Usta MF; Sanabria J; Bivalacqua TJ; Hellstrom WJ
    Int J Impot Res; 2004 Feb; 16(1):73-7. PubMed ID: 14963475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracavernosal injection therapy and surgical therapy in diabetic patients with erectile dysfunction.
    Savoca G; Silvestre G; Belgrano E
    Diabetes Nutr Metab; 2002 Feb; 15(1):53-7. PubMed ID: 11942740
    [No Abstract]   [Full Text] [Related]  

  • 40. Relationship between cavernosal ischemia and corporal veno-occlusive dysfunction in an animal model.
    Azadzoi KM; Park K; Andry C; Goldstein I; Siroky MB
    J Urol; 1997 Mar; 157(3):1011-7. PubMed ID: 9072535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.